Biogen Inc.

BIIB NAS
Pharmaceuticals
Cambridge, MA
2016 Revenue (US$ Millions)$11,449
Revenue Growth (%)6.36%
2015 Revenue (US$ Millions)$10,764
Net Income (US$ Millions)$3,703
Common Shares Outstanding (Millions)215.9
Earnings Per Share (US$)$16.93
Price to Earnings Ratio19.46
Total Equity (US$ Millions)$12,140
Return on Equity (%)39.51%
Long Term Debt (US$ Millions)$6,513
Debt to Equity Ratio (%)0.54%
Market Capitalization (US$ Millions)$61,225
Total Assets (US$ Millions)$22,877
Current Assets (US$ Millions)$8,732
Inventories (US$ Millions)$1,002
Current Liabilities (US$ Millions)$3,420
Cost Of Goods Sold (US$ Millions)$1,479
Asset Turnover0.54
Inventory Turnover1.56